ZA763096B - Peptide preparations with prolonged action - Google Patents

Peptide preparations with prolonged action

Info

Publication number
ZA763096B
ZA763096B ZA00763096A ZA763096A ZA763096B ZA 763096 B ZA763096 B ZA 763096B ZA 00763096 A ZA00763096 A ZA 00763096A ZA 763096 A ZA763096 A ZA 763096A ZA 763096 B ZA763096 B ZA 763096B
Authority
ZA
South Africa
Prior art keywords
prolonged action
peptide preparations
preparations
peptide
prolonged
Prior art date
Application number
ZA00763096A
Inventor
W Rittel
L Geller
R Maier
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZA763096B publication Critical patent/ZA763096B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
ZA00763096A 1975-05-26 1976-05-25 Peptide preparations with prolonged action ZA763096B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH671975 1975-05-26

Publications (1)

Publication Number Publication Date
ZA763096B true ZA763096B (en) 1978-01-25

Family

ID=4313966

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00763096A ZA763096B (en) 1975-05-26 1976-05-25 Peptide preparations with prolonged action

Country Status (14)

Country Link
JP (1) JPS51144721A (en)
AU (1) AU507537B2 (en)
BE (1) BE842189A (en)
CA (1) CA1098444A (en)
DE (1) DE2623074A1 (en)
FR (1) FR2312260A1 (en)
GB (1) GB1548984A (en)
HK (1) HK15982A (en)
IE (1) IE43770B1 (en)
IL (1) IL49653A (en)
MY (1) MY8200284A (en)
NL (1) NL7605559A (en)
NZ (1) NZ180945A (en)
ZA (1) ZA763096B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
NL8701143A (en) * 1986-05-27 1987-12-16 Sandoz Ag PHARMACEUTICAL PREPARATIONS.
NL194638C (en) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol containing solid particles of a pharmaceutically active substance and pharmaceutical preparation containing this hydrosol.
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
GB9120672D0 (en) * 1991-09-28 1991-11-06 Ciba Geigy Ag Pharmaceutical compositions
IT1255895B (en) * 1992-10-20 1995-11-17 Laura Chiodini PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
EP1056443B1 (en) * 1998-02-25 2004-05-06 Abbott Laboratories Butorphanol sustained release formulations
WO2023089240A1 (en) * 2021-11-19 2023-05-25 Nanoform Finland Oyj A composition comprising nanosized active pharmaceutical ingredient

Also Published As

Publication number Publication date
FR2312260B1 (en) 1978-12-08
JPS51144721A (en) 1976-12-13
IL49653A (en) 1979-07-25
IE43770B1 (en) 1981-05-20
BE842189A (en) 1976-11-25
NL7605559A (en) 1976-11-30
FR2312260A1 (en) 1976-12-24
NZ180945A (en) 1978-07-10
HK15982A (en) 1982-04-08
IE43770L (en) 1976-11-26
AU1425276A (en) 1977-12-01
DE2623074A1 (en) 1976-12-09
MY8200284A (en) 1982-12-31
IL49653A0 (en) 1976-07-30
GB1548984A (en) 1979-07-18
CA1098444A (en) 1981-03-31
AU507537B2 (en) 1980-02-21

Similar Documents

Publication Publication Date Title
PT64743A (en) Peptides
JPS57145617A (en) Chair
AU508421B2 (en) Tooch preparations
GB1556251A (en) Chair
JPS522656A (en) Chair
JPS5231073A (en) Peptide and intermediate thereof
ZA765817B (en) Biological preparations
PH14917A (en) Anti-bacterial peptide
JPS51125395A (en) Polypeptide
ZA763096B (en) Peptide preparations with prolonged action
GB1544669A (en) Chair
AU1508976A (en) Chair
JPS51130425A (en) Colddwaterrsoluble preparations
GB1541710A (en) Anthelintic preparations
GB1553524A (en) Peptides
ZA764928B (en) Chair
JPS5212070A (en) Chair
AU514308B2 (en) Polypeptide agents
ZA761147B (en) Protein materials
JPS5245450A (en) Chair
JPS51133434A (en) Sunscreen preparations
CU21074A3 (en) Peptidic derivatives
ZA7627B (en) Pharmaceutical combination preparations
CA39056S (en) Chair
CA39511S (en) Chair